Kura Oncology, Inc. (KURA)
9.345
-0.22
(-2.25%)
USD |
NASDAQ |
May 07, 16:00
9.345
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Research and Development Expense (Annual) : 251.07M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Lexicon Pharmaceuticals, Inc. | 60.50M |
| Novavax, Inc. | 336.82M |
| Liquidia Corp. | 38.45M |